Another chemical giant enters china’s peek market: Mitsubishi Chemical’s Changshu Facility Launches with 600-Ton Capacity Targeting High-End Segment

Zhuan Su Shi Jie learned that recently the Mitsubishi Chemical High-Performance Materials project has officially settled in the Changshu Economic and Technological Development Zone, marking the first time this Japanese chemical giant has established a high-performance engineering plastics production base in China. The project is expected to commence operations by the end of 2026, with a planned annual capacity exceeding 600 tons and projected annual sales exceeding 300 million RMB upon full capacity.

This news has triggered strong attention in the specialty materials industry — at the starting point of the 2025 Chinese PEEK industry landscape transformation, Mitsubishi Chemical's entry will bring what changes to this "top of the pyramid" material sector?

Image source: AI-generated

I. Strategic Move: Why Did Mitsubishi Chemical Choose Changshu?

Mitsubishi Chemical Advanced Materials Division's latest move into Changshu marks its establishment in China.The first production base, marking the beginning of localized production of the group's high-performance engineering plastics products.

The project covers three cutting-edge product lines: Ultra-High Molecular Weight Polyethylene (UHMW-PE), Polyether Ether Ketone (PEEK), and Polyethylene Terephthalate (PET). Among them, PEEK material is directly aimed at the most popular high-tech fields such as humanoid robot joints, medical implants, automotive lightweighting, and aerospace.

Why choose to increase investment in China at this time?

According to ZhuanSu Vision's analysis, this is closely related to Mitsubishi Chemical's strategic transformation. On March 31, 2026, Mitsubishi Chemical announced its exit from the MMA business, transferring all its shares in KMC to CPDC, with the transaction expected to be completed on August 3. The stated reason was "intensifying competition in the MMA market in Asia." Additionally, its 120,000-ton-per-year polycarbonate (PC) plant in Kashima, Japan, is scheduled to cease operations in March 2028, citing the same reason: "oversupply in the market leading to depressed prices."

While exiting traditional businesses characterized by intense competition and declining profitability, Mitsubishi Chemical is intensifying its focus on the high-value-added high-performance engineering plastics sector—a strategy whose intent is unmistakably clear. By selecting China for its first production base, the company not only acknowledges the country’s substantial growth potential but also aims to be closer to the robust demand from emerging downstream industries.

Doubling down on China has become a common choice for many chemical giants. Plastelligence has noticed that since the second half of 2025, international plastic and chemical giants such as BASF, Covestro, SABIC, and Arkema have been actively expanding their production in China.

II. Technical Edge: What Advantages Does Mitsubishi’s PEEK Product Line Offer?

Mitsubishi Chemical is no newcomer in the PEEK field. Its PEEK product line primarily consists of two major series:

Ketron^® PEEKSeries (Industrial Applications)

This product series uses polyetheretherketone resin as the base, featuring a semi-crystalline structure, and exhibits excellent high mechanical performance, high temperature resistance, and chemical corrosion resistance. More notably, Ketron...^®PEEK is an industry leader.The first product certified to NORSOK M-710The qualification barrier for oil and gas application raw material profiles has given Mitsubishi a first-mover advantage in the high-end industrial sector.

Zeniva^® PEEKSeries (Medical Implant Applications)

This series of products is positioned as high-performance, biocompatible polymers, primarily intended for advanced medical applications such as spinal fusion cages, suture anchors, cranio-maxillofacial reconstruction, total knee arthroplasty, and dental implant frameworks. Industry reports indicate that medical-grade PEEK represents the most technologically demanding and highest-value segment within the PEEK market.

At the same time, Mitsubishi Chemical's UHMWPE product line is also not to be underestimated. Its Chirulen.^®And Extrulen^®A series of medical-grade ultra-high-molecular-weight polyethylene has been widely used in implants such as hip, knee, elbow, and shoulder joint prostheses.

III. Competitive Landscape: Intense Competition in China's PEEK Market

The PEEK industry has shown long-term presentationOligopoly structureThe top three global companies collectively hold approximately 80–84% of the market share. UK-based Victrex maintains a dominant “single superpower” position with a market share of 50–60%, while Belgium-based Solvay and Germany-based Evonik follow closely, with annual production capacities of 2,500 tons and 1,800 tons, respectively, accounting for a combined share of approximately 36%.

Image source: Victrex

However, 2025 is dubbed “the starting point of a dramatic shift in China’s PEEK industry landscape,” with numerous domestic listed companies and industry leaders entering the sector across industries. By 2026, this momentum remains strong, and industrial competition has intensified further. Below are the production capacities and market positions of some major global PEEK manufacturers:

Table: Production Capacity of Major Global PEEK Manufacturers

Meanwhile, new production capacities are being rapidly released. Ningbo Huaxiang Holding plans to start production of 4,000 tons of PEEK capacity in the fourth quarter of 2026, Oceanic Bio invests 193 million yuan to build a 2,000-ton capacity, and Huitong Co., Ltd.'s 200-ton phase one project is expected to start production in September 2026.

Mitsubishi Chemical's entry with a 600-ton capacity, although not matching the scale of domestic leaders, will create a differentiated competition in the high-end niche market through its technical expertise and brand influence in medical-grade PEEK.

IV. Surging Demand: Humanoid Robots Ignite a New Engine for PEEK

The core value of PEEK material lies in its lightweight property. With a density of only one-third that of aluminum alloy (1.3 g/cm³ vs. 2.7 g/cm³), it offers eight times the specific strength of aluminum alloy and features inherent "self-lubricating" properties, resulting in significantly lower wear rates compared to metals.

Application Breakthroughs in the Field of Humanoid Robots

Tesla Optimus Gen2 is a benchmark case of PEEK material application in the field of humanoid robots. Each robot uses 6-10 kilograms of PEEK, reducing the overall weight by 15%, extending the range by 31%, and increasing the movement speed by 30%.

According to industry forecasts, if the sales volume of humanoid robots reaches 1 million units, the incremental market size for PEEK will reach RMB 3 billion; if sales exceed 100 million units, the market size will reach RMB 224.3 billion—37 times the current global PEEK market size.

The humanoid robot market is expected to have a compound annual growth rate of 75.39% from 2025 to 2035. Based on the global PEEK capacity of 23,000 tons in 2027, it can only meet the demand for about 1 million humanoid robots. If sales grow rapidly, PEEK material may face a shortage.

Growth in usage within the new energy vehicle sector

PEEK has also attracted significant attention in the field of new energy vehicles. The usage per vehicle has increased from 8-12 grams in traditional fuel vehicles to 180-220 grams in electric vehicles, representing a growth of 15-25 times. This material performs particularly well in 800V high-voltage vehicles and is expected to become a key material for lightweighting in new energy vehicles.

Steadily penetrating the medical implant field

According to MRFR analysis, the PEEK implant market is expected to reach USD 4.401 billion in 2024. The PEEK implants industry is projected to grow from USD 4.746 billion in 2025 to USD 10.09 billion in 2035, with a predicted compound annual growth rate (CAGR) of 7.83% during the forecast period from 2025 to 2035. PEEK is gradually replacing traditional metallic implant materials such as titanium alloys and cobalt-chromium alloys, due to its core advantages, including excellent mechanical strength, low density, superior chemical resistance, matching elastic modulus with human bone tissue, X-ray transparency, and good biocompatibility, and is becoming the mainstream implant material in orthopedic and neurosurgical fields.

According to MRFR data, the Peek implant industry is expected to grow from 4.746 billion USD in 2025 to 10.09 billion USD in 2035.

[Specialty Plastics Vision Observation]

Mitsubishi Chemical's investment in Changshu, with a 600-ton capacity that may seem small, carries significant implications. The Japanese chemical giant is exiting traditional businesses such as MMA and PC, while choosing high-end special materials like PEEK and UHMW-PE as strategic directions, reflecting the global transformation trend in the chemical industry.

For domestic enterprises, technological barriers and certification cycles remain core challenges. Yet, viewed from another perspective, Mitsubishi’s localized production presents greater opportunities for technological spillover and industrial chain collaboration. Amid the wave of domestic substitution, the enterprise that first breaks into high-end application fields will secure a competitive advantage in this billion-yuan-scale race.

PlasticVision will continue to closely monitor PEEK industry developments and provide timely, accurate market insights to enterprises across the upstream and downstream supply chain.

Editor: Lily

Sources: DT New Materials, Chemical Information Weekly, MRFR, Zhuanshu View, etc.